Healthcare startup Doceree has raised Rs 113.5 crore (approximately $13.6 million) from Indian private equity firm Creaegis. The funding was confirmed through a special resolution by Doceree’s board to issue 10 equity shares and 2,4300 Compulsorily Convertible Preference Shares (CCPS) at an issue price of Rs 4,672 per share.
This investment marks a significant milestone for Doceree as it represents the first time the company has received funding through its local Indian entity. Previously, Doceree’s funding rounds were conducted through its holding entity in the United States.
To date, Doceree has secured over $50 million in funding, including $35 million in its Series B round led by Creaegis. In 2022, Doceree raised $11 million in a Series A round led by Eight Road Ventures.
Founded four years ago, Doceree focuses on empowering pharmaceutical and life sciences companies and healthcare media agencies by providing solutions that enhance communication with healthcare professionals (HCPs) across their networks. The ultimate goal is to improve patient health outcomes.
Last year, Doceree expanded its reach into Southeast Asia by collaborating with Hello Health Group, establishing a presence in Vietnam, Indonesia, Malaysia, Cambodia, Myanmar, Singapore, the Philippines, and Taiwan.
Creaegis, which closed its maiden fund at approximately $426 million (Rs 3,500 crore) last year, has a diverse portfolio that includes companies such as Medikabazaar, Zopper, and Kale Logistics. The firm has also made significant investments in Third Wave Coffee and Zopper.
